Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003389661 | SCV001147376 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | KCND3: BP4, BP7 |
Labcorp Genetics |
RCV001402272 | SCV001604117 | likely benign | Spinocerebellar ataxia type 19/22 | 2023-10-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390765 | SCV002704762 | likely benign | Cardiovascular phenotype | 2020-03-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002501244 | SCV002807147 | likely benign | Spinocerebellar ataxia type 19/22; Brugada syndrome 9 | 2021-09-15 | criteria provided, single submitter | clinical testing |